Cellular utilization of Gln is generally initiated by conversion of Gln to glutamate, and inhibition of Glutaminase (GLS) in tumor cells which develop dependent on Gln metabolism deprives cells of glutamate, leading to disruption of tumor metabolic pathways including: macromolecular synthesis, ATP production, and cellular redox homeostasis. This evidence concerns the gene GLS and neoplasm.